|
ZBTB6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.597000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.411000E-01 |
| Normal-vs-Stage2 |
2.305200E-01 |
| Normal-vs-Stage3 |
2.27499999999603E-05 |
| Normal-vs-Stage4 |
1.76001999999675E-05 |
| Stage1-vs-Stage2 |
5.422000E-01 |
| Stage1-vs-Stage3 |
5.79769999999868E-05 |
| Stage1-vs-Stage4 |
1.77088999999686E-05 |
| Stage2-vs-Stage3 |
2.021200E-01 |
| Stage2-vs-Stage4 |
1.493360E-01 |
| Stage3-vs-Stage4 |
7.244600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.284010E-02 |
| Normal-vs-AfricanAmerican |
3.759400E-03 |
| Normal-vs-Asian |
9.126000E-01 |
| Caucasian-vs-AfricanAmerican |
2.470000E-01 |
| Caucasian-vs-Asian |
4.352800E-01 |
| AfricanAmerican-vs-Asian |
1.775450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.718400E-03 |
| Normal-vs-Female |
1.937650E-02 |
| Male-vs-Female |
6.680000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.820100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.017430E-01 |
| Normal-vs-Age(61-80Yrs) |
3.024800E-04 |
| Normal-vs-Age(81-100Yrs) |
7.199700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.637800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.217800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.245200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.804100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.910000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.435800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.802800E-01 |
| Normal-vs-Grade 2 |
4.039800E-01 |
| Normal-vs-Grade 3 |
6.01799999999653E-05 |
| Normal-vs-Grade 4 |
5.11570000027994E-07 |
| Grade 1-vs-Grade 2 |
5.612200E-01 |
| Grade 1-vs-Grade 3 |
3.139900E-02 |
| Grade 1-vs-Grade 4 |
1.616700E-03 |
| Grade 2-vs-Grade 3 |
3.553000E-04 |
| Grade 2-vs-Grade 4 |
5.13249999944954E-07 |
| Grade 3-vs-Grade 4 |
1.763500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.518200E-01 |
| Normal-vs-ccB subtype |
4.232800E-04 |
| ccA subtype-vs-ccB subtype |
6.20230000000221E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.256400E-02 |
| Normal-vs-N1 |
2.697700E-02 |
| N0-vs-N1 |
3.372800E-01 |
|
|
